Inflammatory bowel disease serology in Asia and the West

doi:10.3748/wjg.v19.i37.6207

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 37

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5979)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

407

HTML

3418

Tables (1-2)

193

Sum=4018

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1179

Download

782

Sum=1961

Oct 7, 2013 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 7, 2013; 19(37): 6207-6213
Published online Oct 7, 2013. doi: 10.3748/wjg.v19.i37.6207

Table 2 Antibody positivity and titre according to geography, ethnicity and disease n (%)

	Australia					Hong Kong (all Asian)
	CD	UC		Healthy		CD	UC	Healthy	Relatives
	Caucasian	Caucasian	Asian	Caucasian	Asian	CD	UC	Healthy	Relatives
Total	9	10	10	10	9	12	12	10	8
Antibody positivity
gASCA	6 (67)^a^c	0 (0)	1 (10)	1 (10)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
ALCA	4 (44)^a	1 (10)	0 (0)	2 (20)	0 (0)	1 (8)	1 (8)	0 (0)	0 (0)
ACCA	2 (22)	1 (10)	0 (0)	2 (20)	3 (33)	1 (8)	1 (8)	1 (10)	0 (0)
AMCA	6 (67)^a	0 (0)	0 (0)	1 (10)	3 (33)	7 (58)^a	2 (17)	2 (20)	2 (25)
pANCA	0 (0)	7 (70)^e	5 (50)^e	0 (0)	1 (11)	3 (25)	4 (33)^e	0 (0)	0 (0)
No. of positive antibodies
At least 1	9 (100)^a^c	2 (20)	1 (10)	2 (20)	4 (44)	7 (58)^a	4 (33)	2 (20)	2 (25)
At least 2	6 (67)^a^c	0 (0)	0 (0)	2 (20)	2 (22)	2 (17)	0 (0)	1 (10)	0 (0)
Antibody/QSS titre median (range)
gASCA	59 (146)^a^c	10 (12)	9 (47)	17 (45)	8 (21)	9 (44)	2 (39)	11 (17)	5 (46)
ALCA	46 (79)^a	17 (86)	14 (38)	23 (77)	18 (34)	27 (69)^a	17 (82)	17 (18)	24 (25)
ACCA	50 (188)	39 (101)	43 (56)	60 (310)	76 (135)	50 (80)	37 (87)	46 (77)	34 (62)
AMCA	111 (154)^a	63 (47)	70 (60)	79 (59)	75 (116)	121 (459)^a	60 (272)	59 (145)	74 (94)
QSS	14 (5)^a	9 (6)	10 (6)	12 (8)	9 (10)	13 (10)^a	8 (7)	8 (10)	10 (9)

^aSignificantly higher than all non-Crohn's disease (CD) groups combined (P < 0.05);

^cSignificantly higher than Hong Kong Asian CD (P < 0.05);

^eSignificantly higher than all non-ulcerative colitis (UC) groups combined (P < 0.05). gASCA: Anti-Saccharomyces cerevisiae; ALCA: Anti-laminaribioside carbohydrate IgG antibodies; ACCA: Anti-chitobioside carbohydrate IgA antibodies; AMCA: Anti-mannobioside carbohydrate IgG antibodies; pANCA: Atypical perinuclear anti-neutrophil cytoplasmic antibody; QSS: Quartile sum score.

Citation: Prideaux L, Kamm MA, De Cruz P, van Langenberg DR, Ng SC, Dotan I. Inflammatory bowel disease serology in Asia and the West. World J Gastroenterol 2013; 19(37): 6207-6213
URL: https://www.wjgnet.com/1007-9327/full/v19/i37/6207.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i37.6207